Skip to main content
. 2022 Aug 29;13:941903. doi: 10.3389/fneur.2022.941903

Table 1.

Patient characteristics.

Clinical characteristics Encephalopathy No encephalopathy p-value
(n = 23) (n = 27)
Age, years, mean (SD) 70.7 (12.3) 61.5 (17.1) 0.12
Female, n (%) 12 (52%) 16 (59%) 0.61
Structural injury on imaging, n (%) 12 (52%) 9 (33%) 0.18
Duration of illness prior to EEG, mean (SD) 8.4 (14.7) 5 (6.3) 0.63
WHO COVID severity scale, n (%) 0.002 ¥
Non-severe 14 (61%) 23 (85%)
Severe 7 (30%) 4 (15%)
Critical 2 (9%) 0 (0%)
Past Medical History, n (%)
Dementia 9 (39%) 9 (33%) 0.67
Hypertension 18 (78%) 22 (81%) 0.78
Diabetes 11 (48%) 11 (41%) 0.61
Chronic obstructive pulmonary disorder 5 (22%) 4 (15%) 0.53
BMI > 30, kg/m2 8 (35%) 7 (26%) 0.5
Coronary artery disease 4 (17%) 7 (26%) 0.47
Epilepsy 6 (26%) 9 (33%) 0.58
Clinical Course, n (%)
Dialysis during hospitalization 3 (13%) 3 (11%) 0.83
Sepsis on admission 4 (17%) 2 (7%) 0.28
ARDS 3 (13%) 0 (0%) 0.053
Delirium present on admission 21 (91%) 17 (63%) 0.019
Cefepime 12 (52%) 5 (19%) 0.012
Pneumonia 15 (65%) 10 (37%) 0.047
Intubation 3 (13%) 0 (0%) 0.053
COVID-19 treatment 10 (43%) 3 (11%) 0.009
Renal failure 12 (52%) 7 (26%) 0.0567
Background frequency on EEG, mean (SD) 5.8 (1.1) 9.3 (1.3) n/a
Outcomes
Length of stay, mean (SD) 15.5 (9.9) 8.1 (7.3) 0.001
Disposition, n (%) 0.001 ¥
Death 3 (13%) 0 (0%)
LTACH 1 (4%) 1 (4%)
SAR 13 (57%) 7 (26%)
AR 2 (9%) 3 (11%)
Home 4 (17%) 16 (59%)

ARDS, acute respiratory disease; BMI, body mass index; COVID-19, coronavirus disease 19; WHO, World Health Organization; SD, standard deviation. P-values in bold are significant after Bonferroni correction for 22 comparisons (corrected α = 0.0023).

Two-sample Wilcoxon Rank-Sum test.

Two-tailed Proportions test.

¥

Ordinal logistic regression.